SCHEMBL18565158

SCHEMBL18565158

c1ccc(N(c2ccc3c(c2)c2ccccc2n3-c2ccccc2)c2nc(N(c3ccccc3)c3ccc4c(c3)c3ccccc3n4-c3ccccc3)nc(N(c3ccccc3)c3ccc4c5ccccc5n(-c5ccccc5)c4c3)n2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.47
KDM4E B2RXH2 1/20 0.47
ATM Q13315 1/20 0.47
ALDH1A1 P00352 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
MAPT P10636 2/20 0.34
MEN1 O00255 1/20 0.34
XBP1 P17861 1/20 0.34
MAPK1 P28482 1/20 0.34
NTSR1 P30989 1/20 0.34
KMT2A Q03164 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
REN P00797 1/20 0.34
PTGER4 P35408 1/20 0.34
MAT2A P31153 4/20 0.33
PRMT5 O14744 2/20 0.33
CYP1A2 P05177 1/20 0.33
TSHR P16473 2/20 0.33
MAPK8 P45983 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18565161 1.00 L3MBTL1 (0.47) L3MBTL1KDM4EATMALDH1A1TDP1
SCHEMBL18565187 0.96 L3MBTL1 (0.51) L3MBTL1KDM4EATMALDH1A1TDP1
SCHEMBL18565160 0.96 L3MBTL1 (0.51) L3MBTL1KDM4EATMALDH1A1TDP1
SCHEMBL18565162 0.94 L3MBTL1 (0.42) L3MBTL1KDM4EATMALDH1A1TDP1
SCHEMBL18565128 0.94 L3MBTL1 (0.42) L3MBTL1KDM4EATMALDH1A1TDP1
SCHEMBL18565192 0.94 L3MBTL1 (0.42) L3MBTL1KDM4EATMALDH1A1TDP1
SCHEMBL18565131 0.94 L3MBTL1 (0.42) L3MBTL1KDM4EATMALDH1A1TDP1
SCHEMBL18565151 0.93 L3MBTL1 (0.43) L3MBTL1KDM4EATMALDH1A1TDP1
SCHEMBL18565150 0.93 L3MBTL1 (0.43) L3MBTL1KDM4EATMALDH1A1TDP1
SCHEMBL18565152 0.93 L3MBTL1 (0.43) L3MBTL1KDM4EATMALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10290815-B2 Composition, compound, material for organic electroluminescence element, ink composition, organic electroluminescence element, and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2019-05-14 US disclosed
US-20170062733-A1 COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-03-02 US disclosed
US-20170062733-A1 COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-03-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10290815-B2 Composition, compound, material for organic electroluminescence element, ink composition, organic electroluminescence element, and electronic device EED, BMI1, CD99 L3MBTL1 1263/4885KDM4E 225/4885ATM 3092/4885
US-20170062733-A1 COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE EED, BMI1, CD99 L3MBTL1 1263/4885KDM4E 225/4885ATM 3092/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.